MX2014011123A - Composiciones y metodos de administracion oral de particulas de dietilentriaminopentaacetato encapsuladas. - Google Patents
Composiciones y metodos de administracion oral de particulas de dietilentriaminopentaacetato encapsuladas.Info
- Publication number
- MX2014011123A MX2014011123A MX2014011123A MX2014011123A MX2014011123A MX 2014011123 A MX2014011123 A MX 2014011123A MX 2014011123 A MX2014011123 A MX 2014011123A MX 2014011123 A MX2014011123 A MX 2014011123A MX 2014011123 A MX2014011123 A MX 2014011123A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methods
- encapsulated
- diethylenetriaminepentaacetate
- particles
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 title abstract 3
- 239000002245 particle Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 abstract 1
- 150000003751 zinc Chemical class 0.000 abstract 1
- 239000004246 zinc acetate Substances 0.000 abstract 1
- -1 zinc acetate Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Toxicology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261614333P | 2012-03-22 | 2012-03-22 | |
| US201361771873P | 2013-03-03 | 2013-03-03 | |
| PCT/US2013/031336 WO2013142258A1 (en) | 2012-03-22 | 2013-03-14 | Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2014011123A true MX2014011123A (es) | 2014-12-05 |
Family
ID=48014341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014011123A MX2014011123A (es) | 2012-03-22 | 2013-03-14 | Composiciones y metodos de administracion oral de particulas de dietilentriaminopentaacetato encapsuladas. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9040091B2 (enExample) |
| EP (1) | EP2827853A1 (enExample) |
| JP (1) | JP2015510935A (enExample) |
| KR (1) | KR20140139563A (enExample) |
| AU (1) | AU2013235491A1 (enExample) |
| CA (1) | CA2867701C (enExample) |
| MX (1) | MX2014011123A (enExample) |
| WO (1) | WO2013142258A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6649262B2 (ja) * | 2014-02-18 | 2020-02-19 | メデシス・ファルマ・ソシエテ・アノニムＭｅｄｅｓｉｓ Ｐｈａｒｍａ Ｓ．Ａ． | 放射性核種及び金属のキレート剤を送達するための逆ミセルシステムの使用 |
| JP6810988B2 (ja) | 2015-10-23 | 2021-01-13 | ヴィフォール （インターナショナル） アクチェンゲゼルシャフトＶｉｆｏｒ （Ｉｎｔｅｒｎａｔｉｏｎａｌ） ＡＧ | 新規なフェロポーチン阻害剤 |
| JP2018052884A (ja) * | 2016-09-29 | 2018-04-05 | 菊川 正 | 放射線核種キレート化剤を内包する経口投与剤 |
| JOP20180036A1 (ar) | 2017-04-18 | 2019-01-30 | Vifor Int Ag | أملاح لمثبطات فروبورتين جديدة |
| TW202102478A (zh) | 2019-04-01 | 2021-01-16 | 瑞士商威佛（國際）股份有限公司 | 新穎的鐵螯合物 |
| WO2024253935A1 (en) | 2023-06-05 | 2024-12-12 | Nanopharmaceutics, Inc. | Compositions and methods for oral delivery of sustained release crystalline prx-3140 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| NZ248813A (en) | 1992-11-25 | 1995-06-27 | Eastman Kodak Co | Polymeric grinding media used in grinding pharmaceutical substances |
| TW384224B (en) | 1994-05-25 | 2000-03-11 | Nano Sys Llc | Method of preparing submicron particles of a therapeutic or diagnostic agent |
| US5510118A (en) | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
| UA76810C2 (uk) * | 2001-12-10 | 2006-09-15 | Мерк Енд Ко., Інк. | Фармацевтична композиція антагоніста рецептора тахікініну у формі наночастинок |
| US7910086B1 (en) * | 2005-01-04 | 2011-03-22 | Gp Medical, Inc. | Nanoparticles for protein drug delivery |
| CA2614409C (en) | 2005-07-07 | 2014-05-20 | Nanotherapeutics, Inc | Process for milling and preparing powders and compositions produced thereby |
| AU2007259408B2 (en) * | 2006-02-17 | 2010-03-04 | Sri International | Oral DTPA for radionuclide chelation |
| KR20130100897A (ko) * | 2010-04-21 | 2013-09-12 | 나노메가 메디컬 코포레이션 | 나노입자의 약제학적 조성물 |
-
2013
- 2013-03-14 AU AU2013235491A patent/AU2013235491A1/en not_active Abandoned
- 2013-03-14 US US13/827,667 patent/US9040091B2/en active Active
- 2013-03-14 CA CA2867701A patent/CA2867701C/en active Active
- 2013-03-14 WO PCT/US2013/031336 patent/WO2013142258A1/en not_active Ceased
- 2013-03-14 EP EP13713011.8A patent/EP2827853A1/en not_active Withdrawn
- 2013-03-14 KR KR1020147028955A patent/KR20140139563A/ko not_active Ceased
- 2013-03-14 MX MX2014011123A patent/MX2014011123A/es unknown
- 2013-03-14 JP JP2015501777A patent/JP2015510935A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140139563A (ko) | 2014-12-05 |
| EP2827853A1 (en) | 2015-01-28 |
| AU2013235491A1 (en) | 2014-09-11 |
| CA2867701C (en) | 2020-10-27 |
| CA2867701A1 (en) | 2013-09-26 |
| JP2015510935A (ja) | 2015-04-13 |
| US9040091B2 (en) | 2015-05-26 |
| WO2013142258A1 (en) | 2013-09-26 |
| US20130251815A1 (en) | 2013-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY160249A (en) | Fatty acid fumarate derivatives and their uses | |
| PH12015500301A1 (en) | A novel formulation of diclofenac | |
| MY176814A (en) | Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis | |
| NZ595985A (en) | A novel formulation of naproxen | |
| MX2014011123A (es) | Composiciones y metodos de administracion oral de particulas de dietilentriaminopentaacetato encapsuladas. | |
| MY159208A (en) | A novel formulation of indomethacin | |
| EA201391379A1 (ru) | Фармацевтическая композиция для лечения заболевания в полости рта, содержащая ребамипид | |
| MX2016005668A (es) | Formas cristalinas de compuestos terapeuticos y sus usos. | |
| IN2015DN03854A (enExample) | ||
| PH12016500746A1 (en) | A novel formulation of meloxicam | |
| NZ628433A (en) | Chitosan-derived compositions | |
| MX364220B (es) | Metodos de tratamientos de fibrosis. | |
| MX2015009617A (es) | Formas cristalinas de acido { [1-ciano-5-(4-clorofenoxi)-4-hidroxi -isoquinolin-3-carbonil]-amino}-acetico. | |
| MX366829B (es) | Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas. | |
| PH12016500577A1 (en) | Piperazine derivatives and the use thereof as medicament | |
| GB201317815D0 (en) | Oral supplementation for the reversal of human hair canities | |
| MX2013006670A (es) | Derivado de 2-carboxamida-4-piperazinil-benzofurano. | |
| MX2014014814A (es) | Composicion farmaceutica para el tratamiento de inflamacion y dolor. | |
| WO2013033602A3 (en) | Fatty acid amides, compositions and methods of use | |
| MX2014014816A (es) | Composicion farmaceutica para tratar inflamacion y dolor. | |
| PH12013501896A1 (en) | Use of a sprayable composition comprising ambroxol | |
| MX337593B (es) | Gemcabeno y derivados para tratar la pancreatitis. | |
| WO2012149295A3 (en) | Methods of administering anatabine to treat autism spectrum disorders and seizure disorders | |
| IN2014DN10683A (enExample) | ||
| AU2014208310B2 (en) | A Novel Formulation of Diclofenac |